SHELBY NOVETSKY: Open Payments
NPI 1669258828 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$366 in 20 payments from 6 companies in 2025. Trend: 2023 $91 · 2024 $1,123 · 2025 $366
Food & beverage: $366
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $178 |
| Novo Nordisk Inc | 3 | $60 |
| Lundbeck LLC | 3 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $25 |
Products named: QULIPTA, VYEPTI, Ozempic, FARXIGA, UBRELVY, Auvelity, VAXNEUVANCE, Wegovy.
Industry payments across MI — which companies pay providers there.
